Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News GLP-1 receptor agonists show promise in cutting death and heart risk in psoriasis patients Discover how GLP-1 drugs may slash death and heart risks in psoriasis patients, reshaping care strategies beyond skin treatment. bySoujanya RaviSeptember 18, 2025